These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2889376)

  • 21. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
    Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
    Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
    Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
    J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychopathology and outcome of first-admission schizophrenic patients: hypochondriac-cenestopathic symptoms as predictors of an unfavorable outcome.
    Kobayashi T; Kato S
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):567-72. PubMed ID: 15482590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The possibility of high-quality remission in the long chronic course of schizophrenia].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):80-5. PubMed ID: 19140265
    [No Abstract]   [Full Text] [Related]  

  • 27. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
    Bachmann S; Bottmer C; Schroder J
    Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premorbid sociosexual functioning and long-term outcome in schizophrenia.
    Keefe RS; Mohs RC; Losonczy MF; Davidson M; Silverman JM; Horvath TB; Davis KL
    Am J Psychiatry; 1989 Feb; 146(2):206-11. PubMed ID: 2912262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders.
    Grossman LS; Harrow M; Goldberg JF; Fichtner CG
    Am J Psychiatry; 1991 Oct; 148(10):1359-65. PubMed ID: 1897617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
    Hornung WP; Schonauer K; Feldmann R; Mönking HS
    Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of drug treatment history on comparative effectiveness research in schizophrenia.
    McCombs J; Zolfaghari S; Ganapathy V
    Value Health; 2011; 14(5):679-86. PubMed ID: 21839406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
    Marder SR; Glynn SM; Wirshing WC; Wirshing DA; Ross D; Widmark C; Mintz J; Liberman RP; Blair KE
    Am J Psychiatry; 2003 Aug; 160(8):1405-12. PubMed ID: 12900301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of clinical status of schizophrenic patients by the WAIS comprehension subtest.
    Bigelow LB; Donnelly EP; Torrey EF; Lee CA
    J Clin Psychiatry; 1979 Jun; 40(6):258-61. PubMed ID: 36371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment and course of schizophrenic psychoses over a decade. Disease course and predictors].
    Müller P; Günther U; Lohmeyer J
    Nervenarzt; 1986 Jun; 57(6):332-41. PubMed ID: 2874507
    [No Abstract]   [Full Text] [Related]  

  • 38. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic reassessment and treatment response in schizophrenia.
    Honer WG; Smith GN; MacEwan GW; Kopala L; Altman S; Yorkston N; Ehmann TS; Smith A; Lang M
    J Clin Psychiatry; 1994 Dec; 55(12):528-32. PubMed ID: 7814346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
    Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
    Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.